Lung Cancer Management in Low and Middle-Income Countries
Overview
Pulmonary Medicine
Affiliations
Lung cancer is an increasing problem in the developing world due to rising trends in smoking, high incidence of air pollution, lack of awareness and screening, delayed presentation, and diagnosis at the advanced stage. Even after diagnosis, there are disparities in access to health care facilities and inequitable distribution of resources and treatment options. In addition, the shortage of trained personnel and infrastructure adds to the challenges faced by patients with lung cancer in these regions. A multi-pronged effort targeting tobacco cessation, health promotion and awareness, capacity building, and value-based care are the need of the hour.
Huang F, Lin X, Hong Y, Li Y, Li Y, Chen W BMC Cancer. 2025; 25(1):345.
PMID: 40001094 PMC: 11863806. DOI: 10.1186/s12885-025-13710-2.
Artificial intelligence in precision medicine for lung cancer: A bibliometric analysis.
Wang Y, Zhang W, Liu X, Tian L, Li W, He P Digit Health. 2025; 11:20552076241300229.
PMID: 39758259 PMC: 11696962. DOI: 10.1177/20552076241300229.
Asgedom Y, Kassie G, Habte A, Ketema D, Aragaw F BMJ Open. 2024; 14(12):e088753.
PMID: 39658286 PMC: 11647397. DOI: 10.1136/bmjopen-2024-088753.
Tumor-Activated Neutrophils Promote Lung Cancer Progression through the IL-8/PD-L1 Pathway.
Zheng Y, Cai J, Ji Q, Liu L, Liao K, Dong L Curr Cancer Drug Targets. 2024; 25(3):294-305.
PMID: 39354766 PMC: 11851149. DOI: 10.2174/0115680096337237240909101904.
Xu H, Deng H, Wu Y, Yang Y, Zheng X Front Med (Lausanne). 2024; 11:1279697.
PMID: 39026555 PMC: 11254668. DOI: 10.3389/fmed.2024.1279697.